Search Within

Jose T Baselga

  1. "Radiation Oncology, Department of"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
  3. Research Letter (1)
Groups
  1. GSK Faculty (6)
  2. Radiation Oncology, Department of (6)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (4)
  4. Surgery (4)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  6. Biostatistics Service (3)

More Groups

People
  1. Ahmet Zehir (3)
  2. Dean Bajorin (3)
  3. Howard Scher (3)
  4. Luc Morris (3)
  5. Maurizio Scaltriti (3)
  6. Michael Berger (3)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (1)
  5. 2016 (1)
  6. 2014 (1)
Publications
  1. Blood (1)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. International Journal of Radiation Oncology, Biology, Physics (1)
  5. Nature Communications (1)
  6. Nature Genetics (1)
Publishers
  1. American Association for Cancer Research (2)
  2. Nature Publishing Group (2)
  3. American Society of Hematology (1)
  4. Elsevier Inc. (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Oncologic therapy shapes the fitness landscape of clonal hematopoiesis
    Meeting Abstract

    Bolton, K. L.; Ptashkin, R. N.; Gao, T.; Braunstein, L.; Devlin, S. M.; Patel, M.; Berthon, A.; Syed, A.; Yabe, M.; Coombs, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types
    Research Letter

    Samstein, R. M.; Lee, C. H.; Shoushtari, A. N.; Hellmann, M. D.; Shen, R.; Janjigian, Y. Y.; Barron, D. A.; Zehir, A.; Jordan, E. J.; Omuro, A.; more...
    Nature Genetics (2019)

    Fulltext@MSK | Save
  • Oncologic therapy for solid tumors alters the risk of clonal hematopoiesis
    Meeting Abstract

    Bolton, K.; Ptashkin, R.; Braunstein, L.; Kelly, D.; Devlin, S. M.; Coombs, C. C.; Moarii, M.; Patel, M.; Bernard, E.; Berthon, A.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Tumour-specific PI3K inhibition via nanoparticle-targeted delivery in head and neck squamous cell carcinoma
    Journal Article

    Mizrachi, A.; Shamay, Y.; Shah, J.; Brook, S.; Soong, J.; Rajasekhar, V. K.; Humm, J. L.; Healey, J. H.; Powell, S. N.; Baselga, J.; more...
    Nature Communications (2017)

    Fulltext@MSK | Save
  • Taselisib (GDC-0032), a potent β-sparing small molecule inhibitor of PI3K, radiosensitizes head and neck squamous carcinomas containing activating PIK3CA alterations
    Journal Article

    Zumsteg, Z. S.; Morse, N.; Krigsfeld, G.; Gupta, G.; Higginson, D. S.; Lee, N. Y.; Morris, L.; Ganly, I.; Shiao, S. L.; Powell, S. N.; more...
    Clinical Cancer Research (2016)

    Fulltext@MSK | Save
  • GDC-0032, a novel p110 alpha inhibitor, specifically radiosensitizes head and neck squamous cell carcinomas harboring activating PIK3CA alterations
    Meeting Abstract

    Zumsteg, Z. S.; Morse, N.; Higginson, D.; Gupta, G.; Morris, L.; Ganly, I.; Grandis, J.; Lee, N. Y.; Powell, S. N.; Scaltriti, M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save